COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03787992
Brief Title: Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAG)

First Submitted : December 18, 2018
First Submitted that Met QC Criteria : December 25, 2018
First Posted : December 27, 2018

Last Update Submitted that Met QC Criteria : January 3, 2020
Last Update Posted : January 6, 2020